These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38900600)

  • 21. Effects of Hydrogen Bond Acceptor Ability of Solvents on Molecular Self-Assembly of Sulfadiazine Solvates.
    Zhang X; Wang C; Zhou L; Yang W; Zhou L; Bao Y; Zhang M; Hou B; Xu Z; Yin Q
    J Pharm Sci; 2018 Nov; 107(11):2823-2828. PubMed ID: 30005983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization of a polymorphic hydrate system.
    Tian F; Qu H; Louhi-Kultanen M; Rantanen J
    J Pharm Sci; 2010 Feb; 99(2):753-63. PubMed ID: 19569226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
    Romero S; Escalera B; Bustamante P
    Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
    Wardhana YW; Soewandhi SN; Wikarsa S; Suendo V
    Pak J Pharm Sci; 2019 May; 32(3):981-986. PubMed ID: 31278710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the self-association and desolvation in crystal nucleation.
    Li D; Wang Y; Zong S; Wang N; Li X; Dong Y; Wang T; Huang X; Hao H
    IUCrJ; 2021 May; 8(Pt 3):468-479. PubMed ID: 33953933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic insights into the role of the solvent in the polymorphism of 5-fluorouracil from molecular dynamics simulations.
    Hamad S; Moon C; Catlow CR; Hulme AT; Price SL
    J Phys Chem B; 2006 Feb; 110(7):3323-9. PubMed ID: 16494346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
    Braun DE; Vickers M; Griesser UJ
    Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
    Lange L; Heisel S; Sadowski G
    Molecules; 2016 May; 21(5):. PubMed ID: 27164075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monte Carlo simulations of the solution structure of simple alcohols in water-acetonitrile mixtures.
    Nagy PI; Erhardt PW
    J Phys Chem B; 2005 Mar; 109(12):5855-72. PubMed ID: 16851638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-association during heterogeneous nucleation onto well-defined templates.
    Kulkarni SA; Weber CC; Myerson AS; ter Horst JH
    Langmuir; 2014 Oct; 30(41):12368-75. PubMed ID: 25256225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine solvates.
    Cavallari C; Santos BP; Fini A
    J Pharm Sci; 2013 Nov; 102(11):4046-56. PubMed ID: 23963777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Annealing in the Close Vicinity of
    Kamińska E; Minecka A; Tarnacka M; Hachuła B; Kamiński K; Paluch M
    Mol Pharm; 2020 Mar; 17(3):990-1000. PubMed ID: 31961694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility curves and nucleation rates from molecular dynamics for polymorph prediction - moving beyond lattice energy minimization.
    Parks C; Koswara A; DeVilbiss F; Tung HH; Nere NK; Bordawekar S; Nagy ZK; Ramkrishna D
    Phys Chem Chem Phys; 2017 Feb; 19(7):5285-5295. PubMed ID: 28149994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable-form screening: overcoming trace impurities that inhibit solution-mediated phase transformation to the stable polymorph of sulfamerazine.
    Gong Y; Collman BM; Mehrens SM; Lu E; Miller JM; Blackburn A; Grant DJ
    J Pharm Sci; 2008 Jun; 97(6):2130-44. PubMed ID: 17879974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theoretical study of the competition between intramolecular hydrogen bonds and solvation in the Cys-Asn-Ser tripeptide.
    Soriano-Correa C; Olivares del Valle FJ; Muñoz-Losa A; Fdez Galván I; Martín ME; Aguilar MA
    J Phys Chem B; 2010 Jul; 114(27):8961-70. PubMed ID: 20568808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique mechanism of facile polymorphic conversion of acetaminophen in aqueous medium.
    Gao Y; Olsen KW
    Mol Pharm; 2014 Sep; 11(9):3056-67. PubMed ID: 25111742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ritonavir Revisited: Melt Crystallization Can Easily Find the Late-Appearing Polymorph II and Unexpectedly Discover a New Polymorph III.
    Li S; Liu B; Chen Z; Ou X; Rong H; Lu M
    Mol Pharm; 2023 Aug; 20(8):3854-3863. PubMed ID: 37450774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solvent effects on catechol's binding affinity: investigating the role of the intra-molecular hydrogen bond through a multi-level computational approach.
    Prampolini G; Campetella M; Ferretti A
    Phys Chem Chem Phys; 2023 Jan; 25(3):2523-2536. PubMed ID: 36602108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.